NYMX - Shares of Nymox Pharmaceutical Corporation (NYMX) Surpass 52-Week Low

Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) traded at a new 52-week low today of $1.29. So far today approximately 132,000 shares have been exchanged, as compared to an average 30-day volume of 580,000 shares.

There is potential upside of 24.7% for shares of Nymox Pharmaceutical Corporation based on a current price of $1.35 and an average consensus analyst price target of $1.68.

Nymox Pharmaceutical Corporation share prices have moved between a 52-week high of $3.57 and the current low of $1.29 and are currently at $1.35 per share.

Nymox Pharmaceutical Corp is a biopharmaceutical company. The firm and its subsidiaries specialize in the research and development of drugs and diagnostic products for the aging population. Its product portfolio consists of Nic alert and Tobac alert. The firm has Research and development of products for the aging population reportable segment. It operates mainly in Canada, the United States and Europe and other countries. The company generates a majority of its sales from the United States.

Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected

About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer